Embody is receiving a $2.5 million Phase II research award. Funds will support development and clinical assessment of collagen-based MICROBRACE™ ACL technology for anterior cruciate ligament repair.
OrthoSensor and McLaren Applied formed EnMovi to expand development of MOTIONSENSE™ wearable sensor technology and ORTHOLOGIQ® data analytics for use in orthopedic patient care.
Silver Bullet Therapeutics received CE Mark approval for the OrthoFuzIon™ Bone Screw for reduction and internal fixation procedures anywhere in the body.